Clinical Trials in Yancheng, Jiangsu
6 recruiting
Showing 1–6 of 6 trials
Recruiting
Phase 2
SVRd for the Treatment of Newly Diagnosed Multiple Myeloma Patients Presenting With Extramedullary Disease
Multiple Myeloma
The First Affiliated Hospital with Nanjing Medical University35 enrolled6 locationsNCT05900882
Recruiting
A Prospective Study Comparing DRd With VRd-lite in Elderly Newly Diagnosed Multiple Myeloma
Multiple Myeloma
The First Affiliated Hospital with Nanjing Medical University112 enrolled6 locationsNCT06497738
Recruiting
Phase 4
China Stroke Primary Prevention Trial 2 for Participants With H-type Hypertension and MTHFR 677 CC/CT Genotype (CSPPT2-CC/CT)
HypertensionMTHFR 677 CC or CT GenotypeElevated Plasma Homocysteine (Hcy≥10µmol/L)+1 more
Shenzhen Ausa Pharmed Co.,Ltd32,000 enrolled20 locationsNCT04974138
Recruiting
Phase 4
China Stroke Primary Prevention Trial 2 for Participants With Hypertension and MTHFR 677 TT Genotype
HypertensionMTHFR 677 TT Genotype
Shenzhen Ausa Pharmed Co.,Ltd24,000 enrolled20 locationsNCT04974151
Recruiting
Phase 2
Phase 2 Trial of Adjuvant Adebrelimab Combined With Capecitabine in High-Risk Resected Cholangiocarcinoma: ACHIEVE
Cholangiocarcinoma CancerAdebrelimab (SHR-1316)
The First Affiliated Hospital with Nanjing Medical University122 enrolled4 locationsNCT06607276
Recruiting
Not Applicable
Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm
Lung Adenocarcinoma
Shanghai Pulmonary Hospital, Shanghai, China690 enrolled14 locationsNCT04937283